Company: THC
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001193125-25-079143
Chunk: 79

Company: TENET HEALTHCARE CORP
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 79
---
 Equity Compensation Plans The following table summarizes certain information with respect to our equity compensation plans pursuant to which rights remain outstanding as of December 31, 2024. Equity Compensation Plan Information

| Plan Category                                                 |     | Number of               
 Securities to be        
 Issued Upon             
 Exercise of             
 Outstanding             
 Options,                
 Warrants and Rights (A) |         |    |     | Weighted-   
 Average     
 Exercise    
 Price of    
 Outstanding 
 Options,    
 Warrants    
 and Rights  
 (B)(1)      |       |     | Number of        
 Securities       
 Remaining        
 Available for    
 Future Issuance  
 Under Equity     
 Compensation     
 Plans (Excluding 
 Securities       
 Reflected in     
 Column (A)) (C)  |            |    |
|:--------------------------------------------------------------|:----|:------------------------|--------:|---:|:----|:------------|------:|:----|:-----------------|-----------:|---:|
| Equity compensation plans approved by security holders        |     |                         | 197,943 | -2 |     | $           | 23.76 |     |                  | 10,887,271 | -3 |
| Equity compensation plans not approved by security holders(4) |     |                         |  41,036 |    |     |             |   -0- |     |                  |        -0- |    |
| Total                                                         |     |                         | 239,009 |    |     | $           | 23.76 |     |                  | 10,887,271 |    |

| (1) | The weighted average exercise price does not consider the shares issuable upon the vesting of outstanding RSUs or performance-based RSUs, which have no exercise price. In addition, no exercise price is applicable to the stock units under our deferred compensation plans. |

| (2) | Includes shares subject to outstanding stock options and time-based RSUs and the target number of shares subject to outstanding performance-based RSUs. |

| (3) | Includes 2,468,161 shares remaining available for issuance pursuant to the Tenth Amended and Restated 1995 Employee Stock Purchase Plan and 8,419,110 shares remaining available for issuance under the 2019 Stock Incentive Plan, assuming that all outstanding performance-based RSUs that had not already provisionally vested would settle at target levels. |

| All shares available under the 2019 Stock Incentive Plan may be used for option-based and all